RxDoctor Payments DataLook up a doctor →

Neelima Denduluri

Hematology & Oncology · Arlington, VANPI 1861698946

Payments from drug & device makers

$3,142,471in general payments, 2019–2025

Across 497 payments — averaging $6322.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1.4M
  • Eli Lilly$1.2M
  • Seagen Inc.$165K
  • Daiichi Sankyo Inc.$151K
  • Pfizer$144K
  • Merck$110K
  • plus $37K from 6 others
$26,639in research payments, 2019–2025

Across 2 payments — averaging $13,320 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$21K
  • Amgen$6K

What the payments were for

  • Speaking & faculty fees$1,27047%
  • Travel & lodging$71126%
  • Food & beverage$68826%
  • Education$201%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis14$1,370,931
Eli Lilly9$1,164,869
Seagen Inc.57$164,827
Daiichi Sankyo Inc.181$150,609
Pfizer(2 entities)17$144,040
Merck208$110,115
Immunomedics, Inc.4$23,399
Genentech, Inc.3$12,520
EMD Serono, Inc.1$943
AstraZeneca1$189
Genentech USA, Inc.1$19
Gilead1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,142,471 in reported general payments places this provider in the 95th percentile of 293 hematology & oncology providers in Virginia.

See all hematology & oncology providers in Virginia

Other hematology & oncology in Arlington

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →